Sustaining Remission of Psychotic Depression.

Trial Profile

Sustaining Remission of Psychotic Depression.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Nov 2017

At a glance

  • Drugs Olanzapine (Primary) ; Sertraline
  • Indications Major depressive disorder; Psychotic disorders
  • Focus Therapeutic Use
  • Acronyms STOP-PD; STOP-PD-II
  • Most Recent Events

    • 06 Nov 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Mar 2018.
    • 08 Jun 2017 Planned number of patients changed from 392 to 269.
    • 08 Jun 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top